ヘルスケア相互運用性ソリューションの市場：タイプ（ソフトウェア（EHR、ラボシステム、イメージング、医療情報交換、企業）、サービス）、相互運用性レベル（基礎、構造、セマンティック）、エンドユーザー、地域 - 2027年までの世界予測

Healthcare Interoperability Solutions Market by Type (Software (EHR, Lab System, Imaging, Health Information Exchange, Enterprises), and Services), Interoperability Level (Foundational, Structural, Semantic), End User, and Region - Global Forecast to 2027

ヘルスケア相互運用性ソリューションの世界市場は、2022年の34億米ドルから2027年には62億米ドルに達すると予測され、予測期間中の年平均成長率は12.9%に達するとされています。この市場の成長は、効率的で費用対... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年4月3日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	217	197	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

ヘルスケア相互運用性ソリューションの世界市場は、2022年の34億米ドルから2027年には62億米ドルに達すると予測され、予測期間中の年平均成長率は12.9%に達するとされています。この市場の成長は、効率的で費用対効果の高い医療提供に対する需要の高まり、医療相互運用性に対する政府の資金援助、EHRの急速な普及によってもたらされます。しかし、標準規格の欠如や時代遅れのレガシーシステムの使用は、予測期間中、ヘルスケア相互運用性ソリューション市場の成長をある程度抑制する要因となっています。

"2021年のソフトウェアソリューションの医療機関相互運用性ソリューション市場のタイプ別では、HIE相互運用性ソリューションが急成長している"
2021年のソフトウェアソリューションの医療機関相互運用性ソリューション市場では、HIE相互運用性ソリューションが最大のシェアを占めています。このセグメントの大きなシェアは、投薬や医療ミスの減少による患者の安全性の向上、不必要な書類作成や処理の排除による効率の向上、より効果的なケアや治療のための臨床意思決定支援ツールの介護者への提供といった関連メリットに起因すると考えられる。
"2021年の医療用相互運用性ソリューション市場において、相互運用性のレベル別に最も大きなセグメントを占めたのは「基盤的相互運用性」である"
相互運用性のレベルに基づくと、基礎的な相互運用性セグメントが世界のヘルスケア相互運用性ソリューション市場で最大のシェアを占めています。基礎的相互運用性セグメントの大きなシェアは、異種システム間での安全かつ正確なデータ交換の必要性と、費用対効果の高い基本レベルの相互運用性に対する需要の高まりに起因していると考えられます。
"予測期間中、APACが最も高い成長率を目撃する"
アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると予測されています。APAC地域の市場成長は、主に、新たな国家的相互運用性ポリシーを展開し、公的および民間医療機関と既存のポリシーを再構築するための政府の取り組みの増加、医療観光の増加、患者にコスト効率と品質の高いケアを提供するための医療機器とHCITソリューションの導入・統合のニーズの高まりといった要因によってもたらされます。

主な参加者の内訳は以下の通りです：
- 企業タイプ別：Tier1：55％、Tier2：30％、Tier3：15％。
- Cレベル：50％、ディレクターレベル：35％、その他：15％：15%
- 地域別では、北米：48％、欧州：32％、アジア太平洋：15％、その他の地域：5％。

医療機関向け相互運用性ソリューション市場の主要企業
ヘルスケア相互運用性ソリューション市場で事業を展開する主なプレーヤーは、Oracle Health（米国）、Epic Systems Corporation（米国）、Infor, Inc（米国）、InterSystems Corporation（米国）、Koninklijke Philips N.V.(オランダ）、Veradigm LLC（米国）、Cognizant（米国）、Change Healthcare（米国）、NextGen Healthcare, Inc（米国）、Merative（米国）、Medical Information Technology, Inc（米国）、Lyniate（米国）、OSP Labs（米国）、Orion Health Group of Companies（ニュージーランド）、Onyx Technology LLC（米国）です。その他、ViSolve（米国）、Jitterbit（米国）、iNTERFACEWARE Inc（カナダ）、Virtusa Corp（米国）、Consensus Cloud Solutions Inc（米国）、MphRx（米国）、Wipro（インド）、eMids（米国）、Nalashaa（米国）、Devita LLC（米国）などがあります。
調査対象範囲です：
当レポートでは、医療用相互運用性ソリューション市場を分析し、タイプ、相互運用性のレベル、エンドユーザー、地域に基づいて、さまざまな市場セグメントの市場規模および将来の成長可能性を推定することを目的としています。また、本市場で事業を展開する主要企業の競争分析も行い、企業プロフィール、製品提供、最近の開発状況、主要な市場戦略も併せて掲載しています。
本レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業や小規模な企業にとっても、市場の動向を把握するのに役立ち、ひいては市場シェアの拡大にも貢献します。本レポートを購入された企業は、以下の戦略の1つまたは複数を組み合わせて、市場でのポジションを強化することができます。
本レポートは、以下のような洞察を提供します：
 主な促進要因（効率的で費用対効果の高い医療提供に対する需要の増加、患者のケアと安全性を高めるための政府の取り組みと規制、新しい医療技術の出現、電子カルテの採用拡大）、阻害要因（医療サプライチェーン全体での正確な相互運用性ソリューションの欠如、ITビジネスにおける標準とプロトコルの欠如、病院やクリニックチェーンにおける旧式のレガシーシステムの使用）についての分析、ヘルスケア相互運用ソリューション市場の成長に影響を与える機会（発展途上国におけるヘルスケア相互運用ソリューション市場の拡大、リアルタイムデータ交換のためのソフトウェア技術の進歩）、課題（一貫したデータの欠如による複雑性の増加、熟練したヘルスケアIT専門家の不足、ヘルスケア産業における患者データのセキュリティとプライバシーに関する懸念）があります。
 製品開発/イノベーション：ヘルスケア相互運用性ソリューション市場における今後の技術、研究開発活動、新製品・サービス発表に関する詳細なインサイトを提供します。
 市場開発：有利な新興市場、タイプ、相互運用性のレベル、エンドユーザー、地域に関する包括的な情報。
 市場の多様化：医療用相互運用性ソリューション市場における製品ポートフォリオ、成長地域、最近の開発、投資に関する詳細な情報を提供します。
 競争力評価：Oracle Health（米国）、Epic Systems Corporation（米国）、Infor, Inc（米国）、InterSystems Corporation（米国）、Koninklijke Philips N.V. （オランダ）など、ヘルスケア相互運用性ソリューション市場の主要企業の市場シェア、成長戦略、製品提供、能力を詳細に評価する。

ページTOPに戻る

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.2.2 MARKETS COVERED 30
FIGURE 1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION 30
1.2.3 YEARS CONSIDERED 31
1.3 CURRENCY CONSIDERED 31
1.4 STAKEHOLDERS 32
1.5 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH APPROACH 33
FIGURE 2 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 35
2.1.2.1 Primary sources 35
2.1.2.2 Key data from primary sources 36
2.1.2.3 Insights from primary experts 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37
2.2 MARKET SIZE ESTIMATION 38
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 38
FIGURE 5 CAGR PROJECTIONS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 40
2.2.1 TOP-DOWN APPROACH 40
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 6 DATA TRIANGULATION METHODOLOGY 42
2.4 MARKET RANKING ANALYSIS 43
2.5 STUDY ASSUMPTIONS 43
2.6 RESEARCH LIMITATIONS 44
2.6.1 METHODOLOGY-RELATED LIMITATIONS 44
2.6.2 SCOPE-RELATED LIMITATIONS 44
2.7 RISK ASSESSMENT 44
TABLE 1 RISK ASSESSMENT: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 44
2.8 IMPACT OF ECONOMIC RECESSION ON HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 45
2.8.1 IMPACT OF RUSSIA–UKRAINE WAR 45
2.8.2 IMPACT OF INFLATION 45
3 EXECUTIVE SUMMARY 46
FIGURE 7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 46
FIGURE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2022 VS. 2027 (USD MILLION) 47
FIGURE 9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2022 VS. 2027 (USD MILLION) 48
FIGURE 10 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 49
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 50
4 PREMIUM INSIGHTS 52
4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW 52
FIGURE 12 GOVERNMENT INITIATIVES FOR ENHANCED PATIENT CARE AND SAFETY TO DRIVE MARKET 52
4.2 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE AND COUNTRY (2021) 53
FIGURE 13 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET IN 2021 53
4.3 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 54
FIGURE 14 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 54
4.4 REGIONAL MIX: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET (2022–2027) 54
FIGURE 15 NORTH AMERICA TO DOMINATE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET DURING FORECAST PERIOD 54
4.5 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2022 VS. 2027 55
FIGURE 16 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 17 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
5.2.1 DRIVERS 57
5.2.1.1 Increasing demand for efficient and cost-effective healthcare delivery 57
5.2.1.2 Government initiatives and regulations to enhance patient care and safety 57
5.2.1.3 Emergence of new medical technologies 58
5.2.1.4 Growing adoption of electronic health records 59
5.2.2 RESTRAINTS 59
5.2.2.1 Lack of accurate interoperability solutions across healthcare supply chain 59
5.2.2.2 Lack of standards and protocols in IT businesses 60
5.2.2.3 Use of outdated legacy systems in hospitals and clinic chains 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growing markets for healthcare interoperability solutions in developing countries 61
5.2.3.2 Advancements in software technology for real-time data exchange 62
5.2.4 CHALLENGES 63
5.2.4.1 Increasing complexity due to lack of consistent data 63
5.2.4.2 Shortage of skilled healthcare IT professionals 64
5.2.4.3 Patient data security and privacy concerns in healthcare industry 64
5.3 PRICING ANALYSIS 65
5.4 VALUE CHAIN ANALYSIS 66
FIGURE 18 VALUE CHAIN ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 67
5.5 ECOSYSTEM ANALYSIS 68
FIGURE 19 ECOSYSTEM ANALYSIS OF HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 68
5.6 TECHNOLOGY ANALYSIS 68
5.6.1 APPLICATION PROGRAMMING INTERFACES 68
5.6.2 CLOUD-BASED SOLUTIONS 68
5.6.3 BLOCKCHAIN TECHNOLOGY 68
5.6.4 FAST HEALTHCARE INTEROPERABILITY RESOURCES 69
5.6.5 ARTIFICIAL INTELLIGENCE 69
5.6.6 MACHINE LEARNING 69
5.7 KEY CONFERENCES AND EVENTS IN 2023 69
TABLE 2 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023 69
5.8 REGULATORY ANALYSIS 70
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
5.8.2 LAWS, REGULATIONS, AND STANDARDS 72
TABLE 7 KEY REGULATIONS AND STANDARDS GOVERNING HEALTHCARE INTEROPERABILITY TECHNOLOGIES GLOBALLY 72
5.9 PORTER'S FIVE FORCES ANALYSIS 73
FIGURE 20 PORTER’S FIVE FORCES ANALYSIS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 73
TABLE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS 74
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 74
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 74
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS 74
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%) 75
5.10.2 BUYING CRITERIA 75
FIGURE 22 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 75
TABLE 10 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 75
6 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE 76
6.1 INTRODUCTION 77
TABLE 11 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 77
6.2 SOFTWARE SOLUTIONS 77
TABLE 12 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 78
TABLE 13 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION) 79
6.2.1 EHR INTEROPERABILITY SOLUTIONS 79
6.2.1.1 Large installation base of EHR systems to ensure single and continuous readable documents for physicians 79
TABLE 14 EHR INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 80
TABLE 15 EHR INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.2.2 LAB SYSTEM INTEROPERABILITY SOLUTIONS 81
6.2.2.1 Increasing cost of operations and decreasing reimbursements for laboratory services to boost market 81
TABLE 16 LAB SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 82
TABLE 17 LAB SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 82
6.2.3 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS 83
6.2.3.1 Rising need for data interoperability and increasing usage of smart devices to drive market 83
TABLE 18 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 84
TABLE 19 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
6.2.4 HIE INTEROPERABILITY SOLUTIONS 85
6.2.4.1 Large investments by federal governments to propel market 85
TABLE 20 HIE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 85
TABLE 21 HIE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86
6.2.5 ENTERPRISE INTEROPERABILITY SOLUTIONS 86
6.2.5.1 Advancing software technology and rising demand for expanded care delivery to augment market 86
TABLE 22 ENTERPRISE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 87
TABLE 23 ENTERPRISE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.2.6 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS 87
TABLE 24 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS 88
TABLE 25 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
6.3 SERVICES 89
6.3.1 INCREASING ADOPTION OF HEALTHCARE IT INTEGRATION SERVICES BY PROVIDERS TO AUGMENT MARKET 89
TABLE 26 SERVICES OFFERED BY KEY PLAYERS 90
TABLE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 91
7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL 92
7.1 INTRODUCTION 93
TABLE 28 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 93
7.2 FOUNDATIONAL INTEROPERABILITY 93
7.2.1 NEED FOR SAFE AND ACCURATE DATA EXCHANGE ACROSS DISPARATE SYSTEMS TO FUEL MARKET 93
TABLE 29 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR FOUNDATIONAL INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.3 STRUCTURAL INTEROPERABILITY 94
7.3.1 STRUCTURAL INTEROPERABILITY TO ENSURE INTERPRETATION OF DATA EXCHANGE BETWEEN SYSTEMS AT DATA FIELD LEVEL 94
TABLE 30 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR STRUCTURAL INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.4 SEMANTIC INTEROPERABILITY 96
7.4.1 SEMANTIC INTEROPERABILITY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 96
TABLE 31 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SEMANTIC INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION) 97
8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER 98
8.1 INTRODUCTION 99
TABLE 32 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 99
8.2 HEALTHCARE PROVIDERS 99
TABLE 33 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 34 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION) 101
8.2.1 HOSPITALS & CLINICS 101
8.2.1.1 Increasing patient volume and rising need to reduce errors in data management to augment market 101
TABLE 35 HOSPITALS & CLINICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
8.2.2 LONG-TERM CARE CENTERS 103
8.2.2.1 Increasing number of care centers and need to maintain compliance with medical reforms to propel market 103
TABLE 36 LONG-TERM CARE CENTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
8.2.3 DIAGNOSTIC & IMAGING CENTERS 104
8.2.3.1 Increasing volume of clinical data and need to streamline imaging workflows to drive market 104
TABLE 37 DIAGNOSTIC & IMAGING CENTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 104
8.2.4 OTHER HEALTHCARE PROVIDERS 105
TABLE 38 OTHER HEALTHCARE PROVIDERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 106
8.3 HEALTHCARE PAYERS 106
8.3.1 ADOPTION OF HEALTHCARE INTEROPERABILITY BY PAYERS TO DECREASE HOSPITAL STAYS AND REPEAT TESTS 106
TABLE 39 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2027 (USD MILLION) 107
8.4 PHARMACIES 107
8.4.1 PHARMACIES TO USE HEALTHCARE INFORMATION EXCHANGE SOLUTIONS FOR INDIVIDUALIZED PATIENT CARE AND SUPPORT 107
TABLE 40 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION) 108
9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION 109
9.1 INTRODUCTION 110
TABLE 41 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 110
9.2 NORTH AMERICA 110
FIGURE 23 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT 112
TABLE 42 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 43 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 44 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 45 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 114
TABLE 46 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 114
TABLE 47 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 114
9.2.1 US 115
9.2.1.1 Growing need to curtail healthcare costs to drive market 115
TABLE 48 US: KEY MACROINDICATORS 116
TABLE 49 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 50 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 51 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 117
TABLE 52 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 118
TABLE 53 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 118
9.2.2 CANADA 118
9.2.2.1 Increasing healthcare digitization to support market 118
TABLE 54 CANADA: KEY MACROINDICATORS 119
TABLE 55 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 56 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 57 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 120
TABLE 58 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 121
TABLE 59 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 121
9.3 EUROPE 121
TABLE 60 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 61 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 62 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 63 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 124
TABLE 64 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 124
TABLE 65 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 124
9.3.1 GERMANY 125
9.3.1.1 Modernized healthcare system and increased healthcare expenditure to augment market 125
TABLE 66 GERMANY: KEY MACROINDICATORS 126
TABLE 67 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 68 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 69 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 127
TABLE 70 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 127
TABLE 71 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 127
9.3.2 UK 128
9.3.2.1 Government initiatives and NHS programs to drive demand 128
TABLE 72 UK: KEY MACROINDICATORS 129
TABLE 73 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 74 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 75 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 130
TABLE 76 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 130
TABLE 77 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 130
9.3.3 FRANCE 131
9.3.3.1 Government measures to curtail healthcare expenditures to fuel market 131
TABLE 78 FRANCE: KEY MACROINDICATORS 131
TABLE 79 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 80 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 81 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 132
TABLE 82 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
TABLE 83 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 133
9.3.4 ITALY 133
9.3.4.1 Increasing government initiatives in HCIT technology implementation to aid market 133
TABLE 84 ITALY: KEY MACROINDICATORS 134
TABLE 85 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 86 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 87 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 135
TABLE 88 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 135
TABLE 89 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 136
9.3.5 NETHERLANDS 136
9.3.5.1 Robust healthcare infrastructure and eHealth initiatives to propel market 136
TABLE 90 NETHERLANDS: KEY MACROINDICATORS 137
TABLE 91 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 92 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 93 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 138
TABLE 94 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 138
TABLE 95 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 138
9.3.6 REST OF EUROPE 139
TABLE 96 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 97 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 98 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 140
TABLE 99 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 141
TABLE 100 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 141
9.4 ASIA PACIFIC 141
FIGURE 24 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT 142
TABLE 101 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 143
TABLE 102 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 103 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 104 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 144
TABLE 105 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 144
TABLE 106 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 144
9.4.1 JAPAN 145
9.4.1.1 Japan to be largest healthcare interoperability market in Asia Pacific during forecast period 145
TABLE 107 JAPAN: KEY MACROINDICATORS 145
TABLE 108 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 109 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 110 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 146
TABLE 111 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 146
TABLE 112 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 147
9.4.2 AUSTRALIA 147
9.4.2.1 Increasing government initiatives for better clinical communication to drive market 147
TABLE 113 AUSTRALIA: KEY MACROINDICATORS 147
TABLE 114 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 115 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 116 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 148
TABLE 117 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 149
TABLE 118 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 149
9.4.3 REST OF ASIA PACIFIC 149
TABLE 119 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 120 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 121 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 151
TABLE 122 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 151
TABLE 123 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 151
9.5 LATIN AMERICA 152
9.5.1 IMPLEMENTATION OF FAVORABLE GOVERNMENT INITIATIVES TO DRIVE MARKET 152
TABLE 124 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 125 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 126 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 153
TABLE 127 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 154
TABLE 128 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 154
9.6 MIDDLE EAST & AFRICA 154
9.6.1 INCREASED ESTABLISHMENT OF NEW HOSPITALS TO DRIVE MARKET 154
TABLE 129 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 130 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 131 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION) 156
TABLE 132 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 156
TABLE 133 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION) 156
10 COMPETITIVE LANDSCAPE 157
10.1 INTRODUCTION 157
10.2 KEY STRATEGIES ADOPTED BY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 157
TABLE 134 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: KEY DEVELOPMENTS (JANUARY 2019–MARCH 2023) 158
10.3 MARKET RANKING OF KEY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 159
FIGURE 25 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: MARKET RANKING OF KEY PLAYERS (2022) 159
10.4 MARKET SHARE ANALYSIS 160
10.4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 160
TABLE 135 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2021 161
10.5 COMPETITIVE EVALUATION QUADRANT FOR KEY PLAYERS 161
10.5.1 STARS 161
10.5.2 EMERGING LEADERS 161
10.5.3 PERVASIVE PLAYERS 162
10.5.4 PARTICIPANTS 162
FIGURE 26 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2022) 162
10.6 COMPETITIVE EVALUATION QUADRANT FOR START-UPS/SMES 163
10.6.1 PROGRESSIVE COMPANIES 163
10.6.2 DYNAMIC COMPANIES 163
10.6.3 STARTING BLOCKS 163
10.6.4 RESPONSIVE COMPANIES 163
FIGURE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2022) 164
10.7 COMPETITIVE BENCHMARKING 165
10.7.1 PRODUCT FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 165
TABLE 136 COMPANY PRODUCT FOOTPRINT 165
10.7.2 REGIONAL FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 166
TABLE 137 COMPANY REGION FOOTPRINT 166
10.7.3 FOOTPRINT OF PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 167
TABLE 138 COMPANY FOOTPRINT 167

10.8 COMPETITIVE SCENARIO 168
10.8.1 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS 168
TABLE 139 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2019–2022 168
10.8.2 KEY DEALS 169
TABLE 140 KEY DEALS, 2019–2022 169
11 COMPANY PROFILES 171
11.1 KEY PLAYERS 171
(Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View)*
11.1.1 ORACLE HEALTH 171
TABLE 141 ORACLE HEALTH: COMPANY OVERVIEW 171
FIGURE 28 ORACLE HEALTH: COMPANY SNAPSHOT (2021) 172
11.1.2 EPIC SYSTEMS CORPORATION 175
TABLE 142 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 175
11.1.3 INFOR, INC. 177
TABLE 143 INFOR, INC.: COMPANY OVERVIEW 177
FIGURE 29 INFOR, INC.: COMPANY SNAPSHOT (2019) 177
11.1.4 INTERSYSTEMS CORPORATION 180
TABLE 144 INTERSYSTEMS CORPORATION: COMPANY OVERVIEW 180
11.1.5 KONINKLIJKE PHILIPS N.V. 184
TABLE 145 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 184
FIGURE 30 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021) 185
11.1.6 VERADIGM LLC 187
TABLE 146 VERADIGM LLC: COMPANY OVERVIEW 187
FIGURE 31 VERADIGM LLC: COMPANY SNAPSHOT (2021) 188
11.1.7 COGNIZANT 191
TABLE 147 COGNIZANT: COMPANY OVERVIEW 191
FIGURE 32 COGNIZANT: COMPANY SNAPSHOT (2021) 192
11.1.8 CHANGE HEALTHCARE 194
TABLE 148 CHANGE HEALTHCARE: COMPANY OVERVIEW 194
FIGURE 33 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2021) 194
11.1.9 NEXTGEN HEALTHCARE, INC. 196
TABLE 149 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW 196
FIGURE 34 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2020) 196
11.1.10 MERATIVE 198
TABLE 150 MERATIVE: COMPANY OVERVIEW 198
11.1.11 MEDICAL INFORMATION TECHNOLOGY, INC. 199
TABLE 151 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW 199
FIGURE 35 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT (2019) 200
11.1.12 LYNIATE 201
TABLE 152 LYNIATE: COMPANY OVERVIEW 201

11.1.13 OSP LABS 203
TABLE 153 OSP LABS: COMPANY OVERVIEW 203
11.1.14 ORION HEALTH GROUP OF COMPANIES 204
TABLE 154 ORION HEALTH GROUP OF COMPANIES: COMPANY OVERVIEW 204
FIGURE 36 ORION HEALTH GROUP OF COMPANIES: COMPANY SNAPSHOT (2021) 205
11.1.15 ONYX TECHNOLOGY LLC 206
TABLE 155 ONYX TECHNOLOGY LLC: COMPANY OVERVIEW 206
11.2 OTHER PLAYERS 207
11.2.1 VISOLVE 207
TABLE 156 VISOLVE: COMPANY OVERVIEW 207
11.2.2 JITTERBIT 208
TABLE 157 JITTERBIT: COMPANY OVERVIEW 208
11.2.3 INTERFACEWARE INC. 209
TABLE 158 INTERFACEWARE INC.: COMPANY OVERVIEW 209
11.2.4 VIRTUSA CORP. 210
TABLE 159 VIRTUSA CORP.: COMPANY OVERVIEW 210
FIGURE 37 VIRTUSA CORP.: COMPANY SNAPSHOT (2020) 210
11.2.5 CONSENSUS CLOUD SOLUTIONS INC. 212
TABLE 160 CONSENSUS CLOUD SOLUTIONS INC.: COMPANY OVERVIEW 212
11.2.6 MPHRX 213
11.2.7 WIPRO 214
11.2.8 EMIDS 215
11.2.9 NALASHAA 216
11.2.10 DEEVITA LLC 216
* Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12 APPENDIX 217
12.1 DISCUSSION GUIDE 217
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 220
12.3 CUSTOMIZATION OPTIONS 222
12.4 RELATED REPORTS 222
12.5 AUTHOR DETAILS 223

ページTOPに戻る

Table of Contents

Summary

The global healthcare interoperability solutions market is projected to reach USD 6.2 billion by 2027 from USD 3.4 billion in 2022, at a CAGR of 12.9% during the forecast period. Growth in this market is driven by the increased demand for efficient & cost-effective healthcare delivery, government funding for healthcare interoperability, and the rapid adoption of EHR. However, the lack of standards, and the use of outdated legacy systems are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the forecast period.

“HIE Interoperability Solutions was the fastest-growing segment in the type of healthcare interoperability solutions market for software solutions in 2021”
HIE Interoperability Solutions accounted for the largest share of healthcare interoperability solutions market for software solutions in 2021. The large share of this segment can be attributed to the associated benefits such as improved patient safety by reducing medication and medical errors, increased efficiency by eliminating unnecessary paperwork and handling, as well as providing caregivers with clinical decision support tools for more effective care and treatment.
“Foundational Interoperability accounted for the largest segment by level of interoperaility in the healthcare interoperability solutions market in 2021”
Based on the level of interoperability, the foundational interoperability segment accounted for the largest share of the global healthcare interoperability solutions market. The large share of the foundational interoperability segment can be attributed to the need for safe and accurate data exchange across disparate systems as well as the growing demand for cost-effective basic-level interoperability.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as increasing government initiatives to unfold new national interoperability policies and rework existing policies with public and private healthcare organizations, growing medical tourism, and the growing need for the implementation and integration of medical devices and HCIT solutions to provide cost-effective and quality care to patients.

The break-down of primary participants is as mentioned below:
• By Company Type - Tier 1: 55%, Tier 2: 30%, and Tier 3: 15%
• By Designation - C-level: 50%, Director-level: 35%, and Others: 15%
• By Region - North America: 48%, Europe: 32%, Asia Pacific: 15%, and Rest of the World: 5%.

Key players in the Healthcare interoperability solutions Market
The key players operating in the healthcare interoperability solutions market include Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands), Veradigm LLC (US), Cognizant (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), Merative (US), Medical Information Technology, Inc. (US), Lyniate (US), OSP Labs (US), Orion Health Group of Companies (New Zealand), Onyx Technology LLC (US). Some other players in the market include ViSolve (US), Jitterbit (US), iNTERFACEWARE Inc. (Canada), Virtusa Corp. (US), Consensus Cloud Solutions Inc. (US), MphRx (US), Wipro (India), eMids (US), Nalashaa (US), Deevita LLC (US).
Research Coverage:
The report analyzes the healthcare interoperability solutions market and aims at estimating the market size and future growth potential of various market segments, based on type, level of interoperability, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
 Analysis of key drivers (increasing demand for efficient and cost-effective healthcare delivery, government initiatives and regulations to enhance patient care and safety, emergence of new medical technologies, growing adoption of electronic health records), restraints (lack of accurate interoperability solutions across healthcare supply chain, lack of standards and protocols in IT businesses, use of outdated legacy systems in hospitals and clinic chains), opportunities (growing markets for healthcare interoperability solutions in developing countries, advancements in software technology for real-time data exchange),and challenges (increasing complexity due to lack of consistent data, shortage of skilled healthcare IT professionals, patient data security and privacy concerns in healthcare industry)influencing the growth of the healthcare interoperability solutions market.
 Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare interoperability solutions market.
 Market Development: Comprehensive information on the lucrative emerging markets, type, level of interoperability, end user, and region.
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare interoperability solutions market
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare interoperability solutions market like Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands).

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

MarketsandMarkets社のHealthcare IT分野での最新刊レポート

本レポートと同じKEY WORD（healthcare）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

MarketsandMarkets社のHealthcare IT分野での最新刊レポート

本レポートと同じKEY WORD（healthcare）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?